National Comprehensive Cancer Network

Educational Events & Programs

NCCN 10th Annual Congress:
Hematologic Malignancies™

October 16 – 17, 2015
San Francisco Marriott Marquis
780 Mission Street
San Francisco, CA 94103


Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.

Co-Chairs:
Ranjana H. Advani, MD
Stanford Cancer Institute

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

AGENDA*:

Friday, October 16, 2015

4:30 – 6:00 PM

Registration, Exhibits, and Refreshments

6:00 – 6:15 PM

Opening Remarks

6:15 – 7:05 PM

Patient Case Studies & Panel Discussion
(Double-hit Lymphoma, T-cell Lymphoma, Mantle Cell Lymphoma)

7:10 – 7:35 PM

Optimizing Small Molecular Kinase Inhibitor Therapy for Chronic Lymphocytic Leukemia (CLL)

7:40 – 8:05 PM

Evolving Therapies for Follicular Lymphoma

8:10 – 8:35 PM

HIV-related Hematologic Malignancies

 

Saturday, October 17, 2015

7:00 – 8:00 AM

Registration, Exhibits, and Refreshments

8:00 – 8:05 AM

Opening Remarks

8:05 – 8:55 AM

Patient Case Studies & Panel Discussion 
(Myeloproliferative Disorders, Elderly Myelofibrosis, Hemophagocytic Syndromes)

9:00 – 9:25 AM

Evolving Targeted Management of Acute Myeloid Leukemia (AML)

9:30 – 9:55 AM

Management of Myelodysplastic Syndromes (MDS)

9:55 – 10:25 AM

Break and Exhibits

10:25 – 10:50 AM

Management of Acute Lymphocytic Leukemia (ALL)

10:55 – 11:45 AM

Survivorship Issues: Late Effects of Curative Therapy

11:45 AM – 1:00 PM

Lunch and Exhibits

1:00 – 1:50 PM

Patient Case Studies & Panel Discussion 
(Amyloidosis, POEMS Syndrome, Plasmacytoma)

1:55 – 2:20 PM

Advances in Waldenström Macroglobulinemia

2:25 – 2:50 PM

Management of Multiple Myeloma

2:55 – 3:20 PM

Bone Health in Patients with Multiple Myeloma

3:20 – 3:35 PM

Break and Exhibits

3:35 – 4:00 PM

Diagnosis and Management of Castleman’s Disease

4:05 – 4:30 PM

Advanced Stage Classical Hodgkin Lymphoma (HL): Interm PET-guided Treatment Approach

4:35 – 5:00 PM

Targeted Therapy for Relapsed/Refractory HL

5:00 PM Closing Remarks  

 

This agenda is subject to change. Faculty will be updated as confirmed.


Exhibitor Information

Organizations who are interested in exhibiting at NCCN programs are encouraged to contact Jennifer Tredwell, Senior Director, Marketing.


Please check back often for the most up-to-date information. Please contact 866.788.NCCN (6226) or send an e-mail if you have additional questions.